文献速递糖尿病

血糖控制与蜂窝织炎风险

Glycemic Control and Risk of Cellulitis.
PubMed 文献 · Diabetes Care · 2020-12-01

本研究在大型健康维护组织中分析糖尿病患者血糖控制与感染发生率的关系。共识别407例蜂窝织炎,多因素logistic回归显示HbA1c>7.5%(58 mmol/mol)者蜂窝织炎风险增加1.4倍,HbA1c每升高1%(11 mmol/mol)蜂窝织炎风险增加12%(OR 1.12;CI 1.05-1.19)。

要点

  • HbA1c>7.5%(58 mmol/mol)与蜂窝织炎风险增加1.4倍相关。
  • HbA1c每升高1%(11 mmol/mol),蜂窝织炎风险增加12%(OR 1.12;CI 1.05-1.19)。
  • 口服泼尼松暴露增加蜂窝织炎、肺炎和上呼吸道感染风险。

核心结论

  • 血糖控制不佳与蜂窝织炎的发生相关。
  • 口服泼尼松暴露增加蜂窝织炎、肺炎和上呼吸道感染风险。

研究设计与样本

  • 在大型健康维护组织(HMO)的全部糖尿病患者中,选取每位患者的一次HbA1c检测,并追踪检测后60天内的感染诊断。
  • 采用多因素logistic回归分析HbA1c对感染诊断可能性的独立影响,并控制其他慢性病、糖尿病确诊时长及感染前使用类固醇等混杂因素。

主要发现

  • 共识别407例蜂窝织炎。
  • 多因素logistic回归显示HbA1c>7.5%(58 mmol/mol)者蜂窝织炎风险增加1.4倍。
  • 肥胖、帕金森病、外周血管疾病和既往泼尼松治疗易致蜂窝织炎。
  • HbA1c每升高1%(11 mmol/mol),蜂窝织炎风险增加12%(OR 1.12;CI 1.05-1.19)。
  • HbA1c>7.5%(58 mmol/mol)者肺炎风险呈增加趋势(OR 1.1;CI 0.9-1.4)。

关键数值与推荐

  • 蜂窝织炎风险增加1.4倍对应HbA1c>7.5%(58 mmol/mol)。
  • HbA1c每升高1%(11 mmol/mol),蜂窝织炎OR 1.12(CI 1.05-1.19)。
  • 肺炎风险趋势对应HbA1c>7.5%(58 mmol/mol),OR 1.1(CI 0.9-1.4)。

临床怎么用

  • 对糖尿病患者应关注血糖控制以降低蜂窝织炎风险。
  • 对使用口服泼尼松的患者应警惕蜂窝织炎、肺炎和上呼吸道感染风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We know that diabetes predisposes to common infections, such as cellulitis and pneumonia. However, the correlation between the level of glycemic control and the rate of infection is unknown. RESEARCH DESIGN AND METHODS: We examined the association between glycemic control in patients with diabetes and the incidence of infection in the entire population of patients with diabetes in a large HMO. During the study period, we first selected an HbA1c test for each patient and then searched for an infection diagnosis in the 60 days that followed the test. A multivariate logistic regression analysis was performed to determine the independent effect of HbA1c on the likelihood of being diagnosed with an infection. We were able to control for many confounders, such as other chronic illness, time since the diagnosis of diabetes, and use of steroids before the infection. RESULTS: We identified 407 cases of cellulitis. Multivariate logistic regressions for cellulitis showed a 1.4-fold increased risk among patients with HbA1c >7.5% (58 mmol/mol). Factors such as obesity, Parkinson's disease, peripheral vascular disease, and prior treatment with prednisone predisposed to cellulitis. There was an increase of 12% in the odds of cellulitis for every 1% (11 mmol/mol) elevation in HbA1c (odds ratio [OR] 1.12; CI 1.05-1.19). A similar analysis showed a trend toward an increased risk of pneumonia in patients with HbA1c >7.5% (58 mmol/mol) (OR 1.1; CI 0.9-1.4). CONCLUSIONS: Poor glycemic control was associated in this study with the development of cellulitis. The study also suggests that exposure to oral prednisolone increases the risk of cellulitis, pneumonia, and upper respiratory infection.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Zacay G, Hershkowitz Sikron F, Heymann AD, et al. Glycemic Control and Risk of Cellulitis. Diabetes Care. 2020. PMID: 33262125. doi:10.2337/dc19-1393

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。